Daniel Lynch
Director at SpringWorks Therapeutics, Inc. (SWTX)
Daniel Lynch has filed 17 insider reports with the SEC since February 2021, as director at SpringWorks Therapeutics, Inc. (SWTX), director at 2seventy bio, Inc. (TSVT) and director at bluebird bio, Inc. (BLUE) and at 1 more company. Daniel Lynch made no open-market purchases or sales in the last 12 months. The latest filing, on July 2, 2025, reports sale back to the company at SpringWorks Therapeutics, Inc. (SWTX).
- Filings
- 17
- Companies
- 4
- Bought on market
- None
- Sold on market
- $12.4M
Companies where Daniel Lynch is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 0 | $12.4M | Jul 2, 2025 | ||||
| Director | 21,053 | Jun 15, 2023 | |||||
| Director | 7,959 | Nov 17, 2021 | |||||
| Director | 221,825 | Feb 16, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 1, 2025SWTXDirector Lynch Daniel returned 93,004 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- May 14, 2025SWTXDirector Lynch Daniel was granted 10,060 shares, increasing direct ownership by 12% to 93,004 unitsForm 4Grant or award
- Feb 20, 2025-$2.87MSWTXDirector Lynch Daniel sold $2,866,534 worth of shares (47,600 units at $60.22), decreasing direct ownership by 36% to 82,944 unitsForm 4Open-market sale10b5-1 plan
- Feb 14, 2025-$24KSWTXDirector Lynch Daniel sold $24,000 worth of shares (400 units at $60.00), decreasing direct ownership by 0.31% to 130,544 unitsForm 4Open-market sale10b5-1 plan
- Feb 14, 2025~$2.81MSWTXDaniel Lynch plans to sell 48,000 shares (~$2.81M)Form 144Planned sale10b5-1 plan
- Feb 10, 2025-$9.53MSWTXDirector Lynch Daniel sold $9,530,351 worth of shares (175,000 units at $54.46), decreasing direct ownership by 57% to 130,944 unitsForm 4Open-market sale10b5-1 plan
- Feb 10, 2025~$7.05MSWTXDaniel Lynch plans to sell 175,000 shares (~$7.05M)Form 144Planned sale10b5-1 plan
- May 16, 2024SWTXLynch Daniel was granted 4,095 shares, increasing direct ownership by 1% to 305,944 unitsForm 4Grant or award
- Jun 13, 2023TSVTSEC Form 4 filed by Lynch DanielForm 4Grant or award
- May 24, 2023SWTXSEC Form 4 filed by Lynch DanielForm 4Grant or award
- Jun 8, 2022TSVTSEC Form 4: Lynch Daniel was granted 7,200 shares, increasing direct ownership by 132% to 12,653 unitsForm 4Grant or award
- May 19, 2022SWTXSEC Form 4: Lynch Daniel was granted 4,818 shares, increasing direct ownership by 2% to 297,201 unitsForm 4Grant or award
- Nov 11, 2021BLUESEC Form 4: Lynch Daniel acquired 0 sharesForm 4Other acquisition or disposition
- Nov 11, 2021TSVTSEC Form 4: Lynch Daniel was granted 2,803 shares, increasing direct ownership by 106% to 5,453 unitsForm 4Grant or award
- Jun 15, 2021BLUESEC Form 4: LYNCH DANIEL was granted 4,353 units of Common Stock, increasing direct ownership by 55% to 12,312 unitsForm 4Grant or award
- Dec 17, 2020TBIOSEC Form 5: Daniel Lynch gifted 100,000 units of Common Stock, decreasing ownership by 31% to 221,825 unitsForm 5Gift
- Dec 8, 2020SWTXSEC Form 5: Daniel Lynch gifted 100,000 units of Common Stock, decreasing ownership by 18% to 459,577 unitsForm 5Gift
Also sits on boards with
Officers and directors who share two or more companies with Daniel Lynch.
- Nick Leschly2 shared: BLUE, TSVT
- Sarah JS Glickman2 shared: TSVT, BLUE
- Marcela V. Maus2 shared: TSVT, BLUE
- Denice Torres2 shared: TSVT, BLUE
- William D Baird III2 shared: TSVT, BLUE
- Philip D Gregory2 shared: TSVT, BLUE
- Ramy Ibrahim2 shared: TSVT, BLUE
- William R. Sellers2 shared: BLUE, TSVT
Compare Daniel Lynch with
- Daniel Lynch vs Nick Leschly2 shared
- Daniel Lynch vs Sarah JS Glickman2 shared
- Daniel Lynch vs Marcela V. Maus2 shared
- Daniel Lynch vs Denice Torres2 shared
- Daniel Lynch vs William D Baird III2 shared
- Daniel Lynch vs Philip D Gregory2 shared
Other insiders at the same companies
- Badreddin EdrisSWTX
- Freda C Lewis-HallSWTX
- Julie HambletonSWTX
- Alan FuhrmanSWTX
- Tai-An LinSWTX
- Bhavesh AsharSWTX
- James CassidySWTX
- Martin MackaySWTX
- Carlos AlbanSWTX
- Michael NofiSWTX
- Daniel PichlSWTX
- Francis I Perier JrSWTX
- Saqib IslamSWTX
- Herschel S WeinsteinSWTX
- Joseph VittiglioBLUE
- John O AgwunobiBLUE
Questions about Daniel Lynch
- What is Daniel Lynch's role at SpringWorks Therapeutics, Inc.?
- Daniel Lynch reports to the SEC as director at SpringWorks Therapeutics, Inc. (SWTX), according to the latest filing on July 2, 2025. Daniel Lynch has also filed as director at 2seventy bio, Inc. (TSVT), director at bluebird bio, Inc. (BLUE) and director at Translate Bio, Inc. (TBIO).
- How many shares does Daniel Lynch own?
- After the latest filing that states it, Daniel Lynch directly owned 21,053 shares of 2seventy bio, Inc. (TSVT), 7,959 shares of bluebird bio, Inc. (BLUE) and 221,825 shares of Translate Bio, Inc. (TBIO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Daniel Lynch bought or sold stock recently?
- The most recent open-market sale was on February 20, 2025: sold 47,600 shares of SpringWorks Therapeutics, Inc. (SWTX) for $2.87M at an average of $60.22.
- How do I get alerts when Daniel Lynch files?
- Follow Daniel Lynch on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Daniel Lynch (SEC CIK 0001177082). Totals count each trade once, skipping amendments whose original is on file, from Feb 11, 2021 on. View on SEC EDGAR · Get this as JSON